Literature DB >> 1578135

Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice.

S Shiozawa1, Y Tanaka, T Fujita, T Tokuhisa.   

Abstract

H2-c-fos transgenic (c-fos+) mice are characterized by the inability to raise specific IgG antibodies against immunizing Ag. To examine the contribution of Ag-specific IgG antibody to the development of arthritis, Ag-induced arthritis was produced in c-fos+ mice and their control littermates (c-fos- mice). Intra-articular injection of OVA into c-fos- mice hyperimmunized with OVA induced destructive arthritis with massive lymphocyte infiltration. The c-fos+ mice also developed destructive arthritis comparable in degree with that seen in c-fos- mice. However, joints from the c-fos+ mice had few or no infiltrating lymphocytes. The majority of cells invading the extensively eroded collagenous tissue in the c-fos+ mice had a mesenchymal appearance. These cells, producing excess amounts of c-Fos protein, adhered to and invaded the cartilage matrix when cultured on cartilage slices. These cells, thus, appear to directly cause joint destruction in c-fos+ mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578135

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  The p53 status in juvenile chronic arthritis and rheumatoid arthritis.

Authors:  H Taubert; B Thamm; A Meye; F Bartel; A K Rost; D Heidenreich; V John; J Brandt; M Bache; P Würl; H Schmidt; D Riemann
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.

Authors:  S Shiozawa; K Shimizu; K Tanaka; K Hino
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

3.  The CD44v7/8 epitope as a target to restrain proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  A Wibulswas; D Croft; I Bacarese-Hamilton; P McIntyre; E Genot; I M Kramer
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Activation of synovial fibroblasts in rheumatoid arthritis.

Authors:  R W Kinne; E Palombo-Kinne; F Emmrich
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

6.  Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes.

Authors:  C Xue; M Takahashi; T Hasunuma; H Aono; K Yamamoto; S Yoshino; T Sumida; K Nishioka
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

7.  c-Fos/activator protein-1 transactivates wee1 kinase at G(1)/S to inhibit premature mitosis in antigen-specific Th1 cells.

Authors:  H Kawasaki; K Komai; Z Ouyang; M Murata; M Hikasa; M Ohgiri; S Shiozawa
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

8.  Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells: resistance to cytokine stimulation when the c-fos gene is overexpressed.

Authors:  K Shimizu; H Kawasaki; T Morisawa; M Nakamura; E Yamamoto; N Yoshikawa; M Doita; K Shiozawa; S Yonehara; K Chihara; S Shiozawa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

Review 9.  Treatment of rheumatoid arthritis with IL-1 inhibitors.

Authors:  C Gabay; W P Arend
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.

Authors:  A A van de Loo; O J Arntz; A C Bakker; P L van Lent; M J Jacobs; W B van den Berg
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.